CEP15

gene
On this page

Also known as HT021

Summary

CEP15 (centrosomal protein 15, HGNC:25024) is a protein-coding gene on chromosome 3p14.2, encoding Centrosomal protein 15 (Q9HBI5). May play a role in ciliary assembly.

Predicted to be located in cilium.

Source: NCBI Gene 57415 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 7 total
  • MANE Select transcript: NM_001291941

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25024
Approved symbolCEP15
Namecentrosomal protein 15
Location3p14.2
Locus typegene with protein product
StatusApproved
AliasesHT021
Ensembl geneENSG00000114405
Ensembl biotypeprotein_coding
Entrez57415

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 6 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000232519, ENST00000462069, ENST00000465142, ENST00000486169, ENST00000491323, ENST00000494481, ENST00000542214, ENST00000960035

RefSeq mRNA: 4 — MANE Select: NM_001291941 NM_001291941, NM_001291942, NM_001291943, NM_020685

CCDS: CCDS2896

Canonical transcript exons

ENST00000462069 — 6 exons

ExonStartEnd
ENSE000007735266233132562331399
ENSE000013622636231972162319832
ENSE000018654416231902262319055
ENSE000018814806233325562336213
ENSE000034878106232193062322053
ENSE000035679746232046062320524

Expression profiles

Bgee: expression breadth ubiquitous, 272 present calls, max score 97.98.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.6319 / max 158.0113, expressed in 1506 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
3711012.30811493
371110.8407345
371120.4830218

Top tissues by expression

286 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ponsUBERON:000098897.98gold quality
cortical plateUBERON:000534397.98gold quality
endothelial cellCL:000011597.87gold quality
ganglionic eminenceUBERON:000402397.50gold quality
middle temporal gyrusUBERON:000277197.00gold quality
lateral nuclear group of thalamusUBERON:000273696.58gold quality
orbitofrontal cortexUBERON:000416795.97gold quality
superior vestibular nucleusUBERON:000722795.95gold quality
substantia nigra pars compactaUBERON:000196595.78gold quality
Brodmann (1909) area 23UBERON:001355495.46gold quality
amygdalaUBERON:000187695.42gold quality
dorsolateral prefrontal cortexUBERON:000983495.36gold quality
prefrontal cortexUBERON:000045195.35gold quality
anterior cingulate cortexUBERON:000983595.32gold quality
cingulate cortexUBERON:000302795.29gold quality
dorsal root ganglionUBERON:000004495.22gold quality
temporal lobeUBERON:000187195.16gold quality
islet of LangerhansUBERON:000000695.12gold quality
neocortexUBERON:000195095.04gold quality
frontal cortexUBERON:000187095.03gold quality
parietal lobeUBERON:000187295.02gold quality
postcentral gyrusUBERON:000258194.96gold quality
cerebral cortexUBERON:000095694.89gold quality
substantia nigra pars reticulataUBERON:000196694.89gold quality
superior frontal gyrusUBERON:000266194.87gold quality
entorhinal cortexUBERON:000272894.80gold quality
Brodmann (1909) area 9UBERON:001354094.53gold quality
right frontal lobeUBERON:000281094.52gold quality
spermCL:000001994.46gold quality
nucleus accumbensUBERON:000188294.35gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-CURD-114yes12.42
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

112 targeting CEP15, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-453199.9969.703181
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-548P99.9872.253784
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-477599.9875.006394
HSA-MIR-1213699.9872.815713
HSA-MIR-314899.9775.066478
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-570-3P99.9672.414910
HSA-MIR-3605-5P99.9667.12932
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-302E99.9670.742669
HSA-MIR-141-3P99.9472.792421
HSA-MIR-200A-3P99.9472.682420
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-452599.9464.38675
HSA-MIR-5010-5P99.9464.11705

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioCEP15ENSDARG00000086324
mus_musculusCep15ENSMUSG00000033111
rattus_norvegicusCep15ENSRNOG00000039871

Protein

Protein identifiers

Centrosomal protein 15Q9HBI5 (reviewed: Q9HBI5)

Alternative names: Centrosomal protein 15 kDa

All UniProt accessions (2): Q9HBI5, C9JY17

UniProt curated annotations — full annotation on UniProt →

Function. May play a role in ciliary assembly.

Subcellular location. Cell projection. Cilium.

RefSeq proteins (4): NP_001278870, NP_001278871, NP_001278872, NP_065736 (=MANE)

Domains & families (InterPro)

IDNameType
IPR028006CEP15-likeFamily

Pfam: PF15134

UniProt features (1 total): chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9HBI5-F186.330.63

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 135 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, RODWELL_AGING_KIDNEY_NO_BLOOD_DN, WEI_MYCN_TARGETS_WITH_E_BOX, MODULE_205, RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP, GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN, RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN, HP1SITEFACTOR_Q6, OCT1_06, LIAO_METASTASIS, GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN, CREB_Q2_01

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (2): cilium (GO:0005929), cell projection (GO:0042995)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1
cellular anatomical structure1

Protein interactions and networks

STRING

450 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CEP15J3KS56J3KS56589
CEP15CEP89Q96ST8577
CEP15CCDC77Q9BR77559
CEP15CCDC150Q8NCX0559
CEP15RIBC2Q9H4K1528
CEP15C9orf40Q8IXQ3506
CEP15OTULINLQ9NUU6460
CEP15ZNF367Q7RTV3455
CEP15SATL1Q86VE3449
CEP15DONSONQ9NYP3447
CEP15GOLGA8HP0CJ92447
CEP15TTC1Q99614433
CEP15MGME1Q9BQP7425
CEP15MRPL50Q8N5N7402
CEP15OR13A1Q8NGR1393

IntAct

9 interactions, top by confidence:

ABTypeScore
CEP15SERPINA12psi-mi:“MI:0915”(physical association)0.400
MAPTSHTN1psi-mi:“MI:0914”(association)0.350
CEP15POTEFpsi-mi:“MI:0914”(association)0.350
CEP89CCDC66psi-mi:“MI:2364”(proximity)0.270
CEP15psi-mi:“MI:0915”(physical association)0.000

BioGRID (10): C3orf14 (Proximity Label-MS), C3orf14 (Affinity Capture-RNA), SERPINA12 (Affinity Capture-MS), YES1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), SMPDL3B (Affinity Capture-MS), CEP89 (Affinity Capture-MS), POTEF (Affinity Capture-MS), DDX3Y (Affinity Capture-MS), C3orf14 (Proximity Label-MS)

ESM2 similar proteins: A3KQI3, A4GCK2, A4GZV0, A4WBQ9, A7MEF1, A7SGF0, B2VJD3, D4GGV4, D4HVG6, O17213, O32124, O84672, O85806, P13313, P24445, P37588, P69266, P69267, Q01048, Q08545, Q18446, Q39236, Q4R8E8, Q4S3C1, Q4V8P4, Q4V8S9, Q5RK03, Q67173, Q6FJ19, Q6XTK1, Q77ZK7, Q77ZL2, Q77ZL4, Q7TD12, Q7TPM5, Q80A33, Q89733, Q8BGD0, Q96E40, Q96FH0

Diamond homologs: Q29S20, Q8BGD0, Q9HBI5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

7 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance2
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

773 predictions. Top by Δscore:

VariantEffectΔscore
3:62320458:A:AGacceptor_gain1.0000
3:62320459:G:GGacceptor_gain1.0000
3:62320459:GCTTT:Gacceptor_gain1.0000
3:62320520:GAAAT:Gdonor_gain1.0000
3:62320525:G:GGdonor_gain1.0000
3:62321925:TCTA:Tacceptor_loss1.0000
3:62321926:CTA:Cacceptor_loss1.0000
3:62321927:TAGA:Tacceptor_gain1.0000
3:62321928:A:AGacceptor_gain1.0000
3:62321929:G:GTacceptor_gain1.0000
3:62321929:GA:Gacceptor_gain1.0000
3:62321929:GAGT:Gacceptor_gain1.0000
3:62321929:GAGTA:Gacceptor_gain1.0000
3:62322052:AGG:Adonor_loss1.0000
3:62322054:G:GCdonor_loss1.0000
3:62322054:G:GGdonor_gain1.0000
3:62322055:T:Gdonor_loss1.0000
3:62331396:TGAGG:Tdonor_loss1.0000
3:62331399:GGTG:Gdonor_loss1.0000
3:62331400:G:Adonor_loss1.0000
3:62333254:GACTC:Gacceptor_gain1.0000
3:62319053:TCGGT:Tdonor_loss0.9900
3:62319057:T:Adonor_loss0.9900
3:62319058:G:GGdonor_loss0.9900
3:62320021:A:Tdonor_gain0.9900
3:62320453:A:AGacceptor_gain0.9900
3:62320454:T:Gacceptor_gain0.9900
3:62320454:T:TAacceptor_gain0.9900
3:62320459:GCTT:Gacceptor_gain0.9900
3:62320522:AATG:Adonor_loss0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000314619 (3:62332174 C>T), RS1000417449 (3:62331702 A>G), RS1000429488 (3:62325437 G>A,C,T), RS1000581506 (3:62330197 T>C,G), RS1000656427 (3:62330463 A>G), RS1000686329 (3:62317094 A>G), RS1000846387 (3:62319010 G>A,C,T), RS1000865674 (3:62325666 A>G), RS1001073481 (3:62325813 CAA>C), RS1001165031 (3:62323531 G>A,C), RS1001413484 (3:62330122 A>G), RS1001932940 (3:62323896 C>T), RS1001964044 (3:62324210 C>G), RS1002139714 (3:62317920 G>A), RS1002204283 (3:62318985 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases methylation, affects cotreatment, increases expression, affects expression9
trichostatin Aaffects cotreatment, increases expression3
potassium chromate(VI)affects cotreatment, decreases expression2
Benzo(a)pyrenedecreases expression, increases methylation2
Estradioldecreases expression, affects cotreatment2
bisphenol Adecreases expression1
hydroquinonedecreases expression1
epigallocatechin gallatedecreases expression, affects cotreatment1
gadodiamideincreases expression1
chromium hexavalent iondecreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
ICG 001increases expression1
dorsomorphinaffects cotreatment, increases expression1
Sunitinibdecreases expression1
Vorinostatincreases expression1
Coumestrolincreases expression1
Ketoconazoleincreases expression1
Mitoxantroneaffects response to substance1
Mustard Gasdecreases expression1
Progesteronedecreases expression, affects cotreatment1
Tobacco Smoke Pollutiondecreases expression1
Zincdecreases expression1
Cyclosporinedecreases expression1
Antirheumatic Agentsdecreases expression1
Zinc Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.